AIC-CCMB planning trials for Chikungunya vaccine with indigenously developed mRNA technology
CSIR-Centre for Cellular and Molecular Biology (CCMB) Atal Incubation Centre (AIC) is planning to go ahead with the next stage larger-scale trials of the indigenously developed mRNA vaccine technology for tackling Chikungunya. “Chikungunya is a serious, major debilitating disease in India and it does not yet have a vaccine. We have already demonstrated the ability to … Read more